MedSource
MedSource is a private Houston-based pharmaceutical services company founded in 1997, with 51-100 employees. It appears to provide clinical research and pharmaceutical services to drug development sponsors, based on its leadership in clinical operations and scientific development.
- Company typePrivate
- Founded1997
- HeadquartersHouston, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
What MedSource does
MedSource is a private pharmaceutical services company headquartered in Houston, Texas, founded in 1997. The firm operates with 51-100 employees and is classified as a for-profit private entity. Based on its leadership composition, which includes senior directors of clinical operations and scientific development, MedSource appears to provide clinical research and pharmaceutical services to sponsors, operating in a manner consistent with a mid-sized contract research organization (CRO) or related services provider.
The company's organizational structure reflects a services-oriented operating model: it maintains dedicated business development leadership (VP of Business Development), proposal and contract management (Director of Proposals & Contracts), clinical operations, scientific development, and operational management. This indicates a project-based, contract-driven engagement model typical of pharmaceutical services firms serving drug developers and life sciences clients. However, the source data contains no specific information on product lines, service offerings, technology platforms, pricing, customer segments, or geographic coverage.
Business model mechanics — including how revenue is generated, contract structures, pricing models, and customer relationships — are not documented in the available source material. Multiple source pages returned only placeholder/verification content, creating a substantial data gap around commercial operations, financials, and strategic positioning. As a result, this description is limited to firmographic and leadership-based inferences and should be treated as preliminary.
MedSource firmographics
Firmographics- Name
- MedSource
- Website
- https://medsource.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- MedSource is a private Houston-based pharmaceutical services company founded in 1997, with 51-100 employees. It appears to provide clinical research and pharmaceutical services to drug development sponsors, based on its leadership in clinical operations and scientific development.
- Ownership category
- akta.pro rank
MedSource industry classification
Industry- Product category
- Pharmaceutical Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)
- akta.pro secondary industry
- Medical Affairs, Scientific Communications & HEOR FSP (HLAGAOAG)
Keywords
Where MedSource is headquartered
LocationHeadquarters
- HQ city
- Houston
- HQ country
- United States
- HQ region
- North America
Markets served
MedSource business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
MedSource product offering
Product offeringCore offering
MedSource is a pharmaceutical services company providing clinical operations, business development, proposals and contracts, and scientific development support to clients in the pharmaceutical industry. Founded in 1997 and headquartered in Houston, United States, the firm operates with a 51-100 employee base delivering specialized pharmaceutical services.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Services
Companies that use MedSource
Customer profileIdeal customer profiles1 record
MedSource technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
MedSource partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights1 record
MedSource competitors and assessment
Company assessmentDirect peers
- Medpace Holdings: Mid-to-large CRO offering full-service clinical trial management with a similar sponsor mix of small-to-mid biopharma. Medpace is the most directly comparable publicly traded mid-size CRO to MedSource in terms of operating model and target customer segment.
- Ergomed: UK-based CRO with US operations and a long history in clinical research and pharmacovigilance services. The ergomedcro.com URL appearing in MedSource's data record and overlapping clinical-operations focus make Ergomed a direct comparable for both service line and likely corporate relationship.
- Worldwide Clinical Trials: Mid-size global CRO focused on Phase II–IV trials, particularly in neuroscience, cardiometabolic, and rare disease — directly comparable to MedSource in size, therapeutic scope, and mid-biotech sponsor base.
- Clinipace Worldwide (now d/b/a Caidya): Mid-size CRO offering full-service clinical operations to emerging and mid-sized biopharma. Comparable in size, geographic footprint, and operational model to MedSource.
- Premier Research: Specialty CRO with similar headcount and concentration on small-to-mid biopharma, including analgesia, oncology, and rare disease. Highly comparable in scale and customer profile to MedSource.
Broad incumbents
- IQVIA: Largest global CRO and life sciences services firm, with end-to-end clinical operations, technology, and data capabilities. Relevant as the dominant incumbent against which MedSource competes for mid-biotech study work.
- Parexel International: Large global CRO with a strong biopharma sponsor book and broad therapeutic coverage. Comparable at the incumbent level and a relevant acquirer/competitor dynamic for a mid-size CRO like MedSource.
- Syneos Health: Large clinical and commercial services firm serving biopharma. Competes with MedSource in clinical operations RFPs and provides a useful reference point on broader industry economics and consolidation trends.
- ICON plc: Top-three global CRO offering clinical operations, FSP, and laboratory services. Sets the competitive ceiling on full-service mid-size CRO deals and represents a likely acquirer profile for firms like MedSource.
- Labcorp Drug Development (now Fortrea): Large clinical CRO spun out of Labcorp. Competes for the same mid-to-large sponsor work as MedSource and is a benchmark for clinical-operations scale and capability.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat2 records
Key risks4 records
Key highlights4 records
Customer concentration
MedSource social profiles
Digital presenceMedSource financial estimates
Financial estimateRevenue estimate
Valuation estimate
MedSource leadership team
Management profileNumber of profiles
Profiles7 records
MedSource funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MedSource M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MedSource
What does MedSource do?
MedSource is a pharmaceutical services company providing clinical operations, business development, proposals and contracts, and scientific development support to clients in the pharmaceutical industry. Founded in 1997 and headquartered in Houston, United States, the firm operates with a 51-100 employee base delivering specialized pharmaceutical services.
Is MedSource a public or private company?
MedSource is a private company. It is classified as unknown and is currently operating.
When was MedSource founded?
MedSource was founded in 1997. It employs 51 to 100 people.
Where is MedSource based?
MedSource is headquartered in Houston, United States, in the North America region.
Who are MedSource's main competitors?
Direct peers on record are Medpace Holdings, Ergomed, Worldwide Clinical Trials, Clinipace Worldwide (now d/b/a Caidya) and Premier Research. Broad incumbents are IQVIA, Parexel International, Syneos Health, ICON plc and Labcorp Drug Development (now Fortrea).
Does MedSource have an API?
No public API is recorded for MedSource.
What industry is MedSource in?
MedSource's product category is Pharmaceutical Services. Its primary akta.pro industry code is HLAGAOAA, Clinical Operations & Monitoring FSP (CRA/CTM/Start-up), with a secondary code of HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54171 and its SIC code is 8000.